A.i.r. Platform™: Configuring Autoinjector Performance to Drug Profiles, Users, and Brand Identity—While Retaining Platform Speed, Scale, and Economics

A.i.r. Platform™ is a fully customizable autoinjector platform developed by MGS for pharma teams seeking greater control than conventional platform devices. Its differentiation lies in a common architectural framework in which the core drive can be adapted, supported by a suite of modular elements that broaden the accessible design space. This enables customization for fit to patient, fit to drug, and fit to brand—spanning device behavior (e.g., fill volume, viscosity, activation profile etc.), user experience (e.g., shapes, sizes, windows etc.), and visual identity e.g., (colors, embossments), with optional sustainability choices (e.g., linear and circular). The session will highlight what makes the platform unique, how it was developed, and how pharma can onboard—from configuration through validation, industrialization, and scale-up—while preserving platform advantages in speed, scale readiness, flexibility across programs, and economics.